A phase I trial of SAR 127963 for traumatic brain injury.
Latest Information Update: 02 May 2012
Price :
$35 *
At a glance
- Drugs SAR 127963 (Primary)
- Indications Traumatic brain injuries
- Focus Adverse reactions; Therapeutic Use
- 27 Apr 2012 New trial record